Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.ABSTRACTGastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. We provide an overview of the most important practice-changing trials that were either published or presented at the international scientific meetings in 2021-2023. Highlights included reports on three phase III trials (CONCORDE/PRODIGE 26, ARTDECO, and a study by Xu et al.) that evaluated dose escalation in the definitive setting for locally advanced oesophageal cancers, as well as two phase III trials that evalua...
Source: Cancer Radiotherapie - February 28, 2024 Category: Cancer & Oncology Authors: J Boustani F Huguet V Vendrely Source Type: research
Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.ABSTRACTGastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. We provide an overview of the most important practice-changing trials that were either published or presented at the international scientific meetings in 2021-2023. Highlights included reports on three phase III trials (CONCORDE/PRODIGE 26, ARTDECO, and a study by Xu et al.) that evaluated dose escalation in the definitive setting for locally advanced oesophageal cancers, as well as two phase III trials that evalua...
Source: Cancer Radiotherapie - February 28, 2024 Category: Cancer & Oncology Authors: J Boustani F Huguet V Vendrely Source Type: research
Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.ABSTRACTGastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. We provide an overview of the most important practice-changing trials that were either published or presented at the international scientific meetings in 2021-2023. Highlights included reports on three phase III trials (CONCORDE/PRODIGE 26, ARTDECO, and a study by Xu et al.) that evaluated dose escalation in the definitive setting for locally advanced oesophageal cancers, as well as two phase III trials that evalua...
Source: Cancer Radiotherapie - February 28, 2024 Category: Cancer & Oncology Authors: J Boustani F Huguet V Vendrely Source Type: research
Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.ABSTRACTGastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. We provide an overview of the most important practice-changing trials that were either published or presented at the international scientific meetings in 2021-2023. Highlights included reports on three phase III trials (CONCORDE/PRODIGE 26, ARTDECO, and a study by Xu et al.) that evaluated dose escalation in the definitive setting for locally advanced oesophageal cancers, as well as two phase III trials that evalua...
Source: Cancer Radiotherapie - February 28, 2024 Category: Cancer & Oncology Authors: J Boustani F Huguet V Vendrely Source Type: research
Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.ABSTRACTGastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. We provide an overview of the most important practice-changing trials that were either published or presented at the international scientific meetings in 2021-2023. Highlights included reports on three phase III trials (CONCORDE/PRODIGE 26, ARTDECO, and a study by Xu et al.) that evaluated dose escalation in the definitive setting for locally advanced oesophageal cancers, as well as two phase III trials that evalua...
Source: Cancer Radiotherapie - February 28, 2024 Category: Cancer & Oncology Authors: J Boustani F Huguet V Vendrely Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report
We report here the case of a patient with intracardiac metastasis secondary to malignant adrenocortical carcinoma, treated with magnetic resonance imaging-guided stereotactic radiotherapy.PMID:38341326 | DOI:10.1016/j.canrad.2023.06.033 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - February 10, 2024 Category: Cancer & Oncology Authors: M Michalet R T étreau J-L Pasqui é O Chabre D Azria Source Type: research
